COST-EFFECTIVENESS OF DONEPEZIL IN THE TREATMENT OF PATIENTS WITH ALZHEIMER'S DISEASE: AN UPDATE

被引：0
|
作者：
Chyr, L. C. [1 ]
Yapici, H. O. [1 ]
Padula, W., V [1 ]
机构：
[1] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.1399
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PND26
引用
收藏
页码：S206 / S206
页数：1
相关论文
共 50 条
  • [21] STRUCTURAL UNCERTAINTY IN COST-EFFECTIVENESS MODELS OF TREATMENT FOR ALZHEIMER'S DISEASE
    Peters, J. L.
    Hoyle, M.
    Anderson, R.
    VALUE IN HEALTH, 2010, 13 (07) : A240 - A240
  • [22] Cost-effectiveness of donepezil and memantine in moderate to severe Alzheimer's disease (the DOMINO-AD trial)
    Knapp, Martin
    King, Derek
    Romeo, Renee
    Adams, Jessica
    Baldwin, Ashley
    Ballard, Clive
    Banerjee, Sube
    Barber, Robert
    Bentham, Peter
    Brown, Richard G.
    Burns, Alistair
    Dening, Tom
    Findlay, David
    Holmes, Clive
    Johnson, Tony
    Jones, Robert
    Katona, Cornelius
    Lindesay, James
    Macharouthu, Ajay
    McKeith, Ian
    McShane, Rupert
    O'Brien, John T.
    Phillips, Patrick P. J.
    Sheehan, Bart
    Howard, Robert
    INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, 2017, 32 (12) : 1205 - 1216
  • [23] An Outline For a Cost-Effectiveness Analysis of a Drug For Patients With Alzheimer’s Disease
    Jan J.V. Busschbach
    Werner B.F. Brouwer
    Adrianus van der Donk
    Jan Passchier
    Frans F.H. Rutten
    PharmacoEconomics, 1998, 13 : 21 - 34
  • [24] The cost-effectiveness of quetiapine for Alzheimer's disease in community dwelling patients
    Getsios, D
    Proskorovsky, I
    Caro, JJ
    O'Brien, J
    Pesa, J
    Ward, AJ
    VALUE IN HEALTH, 2005, 8 (03) : 315 - 315
  • [25] An outline for a cost-effectiveness analysis of a drug for patients with Alzheimer's disease
    Busschbach, JJV
    Brouwer, WBF
    van der Donk, A
    Passchier, J
    Rutten, FFH
    PHARMACOECONOMICS, 1998, 13 (01) : 21 - 34
  • [26] The cost-effectiveness of a behavior intervention with caregivers of patients with Alzheimer's disease
    Nichols, Linda O.
    Chang, Cyril
    Lummus, Allan
    Burns, Robert
    Martindale-Adams, Jennifer
    Graney, Marshall J.
    Coon, David W.
    Czaja, Sara
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2008, 56 (03) : 413 - 420
  • [27] Is donepezil cost-effective in the treatment of Alzheimer's disease?
    Sobolewski, M
    Kuzniar, J
    Splawinski, J
    NEUROBIOLOGY OF AGING, 2002, 23 (01) : S97 - S97
  • [28] Modeling cost-effectiveness of pharmaceuticals in Alzheimer's disease
    Oremus, Mark
    Tarride, Jean-Eric
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (03) : 275 - 277
  • [29] COST-EFFECTIVENESS OF MEMANTINE IN THE TREATMENT OF MODERATE TO SEVERE ALZHEIMER'S DISEASE IN NORWAY
    Toumi, M.
    Lamure, M.
    Grishchenko, M.
    Cochran, J.
    Rive, B.
    VALUE IN HEALTH, 2009, 12 (07) : A370 - A370
  • [30] Cost-effectiveness analysis of the treatment of mild and moderate Alzheimer's disease in Brazil
    da Silva, Luciana R.
    Vianna, Cid M. M.
    Mosegui, Gabriela B. G.
    Peregrino, Antonio A. F.
    Marinho, Valeska
    Laks, Jerson
    BRAZILIAN JOURNAL OF PSYCHIATRY, 2019, 41 (03) : 218 - 224
12345